Utilization and Safety of Ipilimumab Plus Nivolumab in a Real-World Cohort of Metastatic Renal Cell Carcinoma Patients

Myuran Thana; Naveen S. Basappa; Sunita Ghosh; Christian K. Kollmannsberger; Daniel Y.C. Heng; Aaron R. Hansen; Jeffery Graham; Denis Soulières; Martin Neil Reaume; Aly Khan A. Lalani; Vincent Castonguay; Georg A. Bjarnason; François Patenaude; Rodney H. Breau; Frédéric Pouliot; Anil Kapoor; Lori A. Wood

doi:10.1016/j.clgc.2021.12.003

Utilization and Safety of Ipilimumab Plus Nivolumab in a Real-World Cohort of Metastatic Renal Cell Carcinoma Patients

Myuran Thana, Naveen S. Basappa, Sunita Ghosh, Christian K. Kollmannsberger, Daniel Y.C. Heng, Aaron R. Hansen, Jeffery Graham, Denis Soulières, Martin Neil Reaume, Aly Khan A. Lalani, Vincent Castonguay, Georg A. Bjarnason, François Patenaude, Rodney H. Breau, Frédéric Pouliot, Anil Kapoor, Lori A. Wood

Research output: Contribution to journal › Article › peer-review

3 Citations (Scopus)

Original language	English
Pages (from-to)	210-218
Number of pages	9
Journal	Clinical Genitourinary Cancer
Volume	20
Issue number	3
DOIs	https://doi.org/10.1016/j.clgc.2021.12.003
Publication status	Published - Jun 2022
Externally published	Yes

ASJC Scopus Subject Areas

Urology
Oncology

Keywords

Immune checkpoint inhibitors
Immune-related adverse effects
Immuno-oncology
Immunotherapy
Retrospective

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.clgc.2021.12.003

Cite this

Thana, M., Basappa, N. S., Ghosh, S., Kollmannsberger, C. K., Heng, D. Y. C., Hansen, A. R., Graham, J., Soulières, D., Reaume, M. N., Lalani, A. K. A., Castonguay, V., Bjarnason, G. A., Patenaude, F., Breau, R. H., Pouliot, F., Kapoor, A., & Wood, L. A. (2022). Utilization and Safety of Ipilimumab Plus Nivolumab in a Real-World Cohort of Metastatic Renal Cell Carcinoma Patients. Clinical Genitourinary Cancer, 20(3), 210-218. https://doi.org/10.1016/j.clgc.2021.12.003

Thana, M, Basappa, NS, Ghosh, S, Kollmannsberger, CK, Heng, DYC, Hansen, AR, Graham, J, Soulières, D, Reaume, MN, Lalani, AKA, Castonguay, V, Bjarnason, GA, Patenaude, F, Breau, RH, Pouliot, F, Kapoor, A & Wood, LA 2022, 'Utilization and Safety of Ipilimumab Plus Nivolumab in a Real-World Cohort of Metastatic Renal Cell Carcinoma Patients', Clinical Genitourinary Cancer, vol. 20, no. 3, pp. 210-218. https://doi.org/10.1016/j.clgc.2021.12.003

@article{54fae79b6e184d77ac4ca96bacd836de,

title = "Utilization and Safety of Ipilimumab Plus Nivolumab in a Real-World Cohort of Metastatic Renal Cell Carcinoma Patients",

keywords = "Immune checkpoint inhibitors, Immune-related adverse effects, Immuno-oncology, Immunotherapy, Retrospective",

author = "Myuran Thana and Basappa, {Naveen S.} and Sunita Ghosh and Kollmannsberger, {Christian K.} and Heng, {Daniel Y.C.} and Hansen, {Aaron R.} and Jeffery Graham and Denis Souli{\`e}res and Reaume, {Martin Neil} and Lalani, {Aly Khan A.} and Vincent Castonguay and Bjarnason, {Georg A.} and Fran{\c c}ois Patenaude and Breau, {Rodney H.} and Fr{\'e}d{\'e}ric Pouliot and Anil Kapoor and Wood, {Lori A.}",

note = "Publisher Copyright: {\textcopyright} 2021",

year = "2022",

month = jun,

doi = "10.1016/j.clgc.2021.12.003",

language = "English",

volume = "20",

pages = "210--218",

journal = "Clinical Genitourinary Cancer",

issn = "1558-7673",

publisher = "Elsevier",

number = "3",

}

TY - JOUR

T1 - Utilization and Safety of Ipilimumab Plus Nivolumab in a Real-World Cohort of Metastatic Renal Cell Carcinoma Patients

AU - Thana, Myuran

AU - Basappa, Naveen S.

AU - Ghosh, Sunita

AU - Kollmannsberger, Christian K.

AU - Heng, Daniel Y.C.

AU - Hansen, Aaron R.

AU - Graham, Jeffery

AU - Soulières, Denis

AU - Reaume, Martin Neil

AU - Lalani, Aly Khan A.

AU - Castonguay, Vincent

AU - Bjarnason, Georg A.

AU - Patenaude, François

AU - Breau, Rodney H.

AU - Pouliot, Frédéric

AU - Kapoor, Anil

AU - Wood, Lori A.

PY - 2022/6

Y1 - 2022/6

KW - Immune checkpoint inhibitors

KW - Immune-related adverse effects

KW - Immuno-oncology

KW - Immunotherapy

KW - Retrospective

UR - http://www.scopus.com/inward/record.url?scp=85123871032&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85123871032&partnerID=8YFLogxK

U2 - 10.1016/j.clgc.2021.12.003

DO - 10.1016/j.clgc.2021.12.003

M3 - Article

AN - SCOPUS:85123871032

SN - 1558-7673

VL - 20

SP - 210

EP - 218

JO - Clinical Genitourinary Cancer

JF - Clinical Genitourinary Cancer

IS - 3

ER -

Utilization and Safety of Ipilimumab Plus Nivolumab in a Real-World Cohort of Metastatic Renal Cell Carcinoma Patients

ASJC Scopus Subject Areas

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this